Follow us on

Q of the week

Q: How Do You Get Shingles?

Get the Answer: 

Crohn's disease

Crohn's disease is an ongoing condition that causes inflammation of the digestive tract, or the GI (gastrointestinal) tract (the gut).
Select RSS URL
Investigational immunotherapy was safe, tolerable, and showed some activity against melanoma
Source:  Clinical Trials/Drug Trials News from Medical News Today
The investigational immunotherapeutic IMC-20D7S was safe, well tolerated, and showed signs of modest clinical activity for patients with advanced melanoma, according to results from a...
Positive pivotal Phase 3 data announced demonstrating investigational Elagolix reduced endometriosis-associated pain
Source:  Clinical Trials/Drug Trials News from Medical News Today
AbbVie, a global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc.
Depression could be treated with anti-inflammatory drugs
Source:  Clinical Trials/Drug Trials News from Medical News Today
A new meta-analysis finds a new class of drugs used to treat inflammation in autoimmune diseases may also be an effective treatment for depression.
The placebo effect: Knowingly taking sham pills may reduce chronic pain
Source:  Clinical Trials/Drug Trials News from Medical News Today
New study suggests it is not the expectation that a 'dummy pill' is real that elicits the placebo effect, but rather the ritual associated with taking it.
Caffeine did not induce arrhythmia in trial with heart failure patients
Source:  Clinical Trials/Drug Trials News from Medical News Today
A trial where heart failure patients ingested 500 mg caffeine over 5 hours found no raised risk of arrhythmic episodes, even during treadmill stress test.
Breast cancer drug shows potential in patients with skin metastases
Source:  Clinical Trials/Drug Trials News from Medical News Today
A study presented at the ESMO Congress reveals how the drug tucatinib led to a reduction in skin metastases for patients with breast cancer.
Cabozantinib improves progression-free survival in metastatic renal cell carcinoma
Source:  Clinical Trials/Drug Trials News from Medical News Today
Cabozantinib significantly improves progression-free survival and response rate in patients with metastatic renal cell carcinoma compared to sunitinib, according to research presented at the ESMO...
MEK inhibition in KRAS-mutant non-small-cell lung cancer (NSCLC) did not improve survival
Source:  Clinical Trials/Drug Trials News from Medical News Today
MEK inhibitor selumetinib in combination with docetaxel does not improve progression free or overall survival in individuals with KRAS-mutant non-small-cell lung cancer (NSCLC), according to data...
Custirsen shows no survival benefits in metastatic prostate cancer
Source:  Clinical Trials/Drug Trials News from Medical News Today
A phase III randomized controlled trial of custirsen in combination with cabazitaxel/prednisone in patients with previously-treated metastatic, castration-resistant prostate cancer has shown no...
Greater patient selection may be needed for first line nivolumab to improve progression-free survival in advanced lung cancer
Source:  Clinical Trials/Drug Trials News from Medical News Today
Greater patient selection may be needed for first line nivolumab to improve progression-free survival over chemotherapy in advanced lung cancer as the CheckMate 026 trial gave negative results in a...